Duality Biotherapeutics Stock Forecast

Stock Price Forecast

According to 8 analysts polled by S&P Global, Duality Biotherapeutics stock has a consensus rating of "Strong Buy" and an average price target of $433.97. The average 1-year stock price forecast is 94.61% higher than the current stock price, while the lowest is $369.85 (+65.85%) and the highest is $507.74 (+127.69%).

Price Target: $433.97 (+94.61%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$369.85	$433.97	$437.76	$507.74
Change	+65.85%	+94.61%	+96.30%	+127.69%

* Price targets were last updated on Apr 10, 2026.

Analyst Ratings

The average analyst rating for Duality Biotherapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	6	6	6	6	6	6
Buy	2	2	2	2	2	2
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	8	8	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst GF Securities No rating	GF Securities	Buy Maintains $520.49	Buy	Maintains	$520.49	+133.40%	Apr 10, 2026
Unknown Analyst Guotai Haitong No rating	Guotai Haitong	Buy Maintains $457.74	Buy	Maintains	$457.74	+105.26%	Apr 9, 2026
Unknown Analyst KeyBanc No rating	KeyBanc	Buy Maintains $425.63	Buy	Maintains	$425.63	+90.87%	Apr 1, 2026
Jill Wu CMB International Securities	CMB International Securities	Buy Maintains $383.47	Buy	Maintains	$383.47	+71.96%	Mar 30, 2026
Unknown Analyst CICC No rating	CICC	Buy Maintains $430.00	Buy	Maintains	$430.00	+92.83%	Mar 27, 2026

More Analyst Ratings

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.